Aclaris therapeutics provides corporate update

- ati-1777 phase 2a trial results published in jid innovations - - ati-1777 phase 2b trial topline data anticipated in january 2024 - - aclaris announces reduction in workforce -

ACRS Ratings Summary

ACRS Quant Ranking